Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Guha Udayan — NextCure, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Guha Udayan

Guha Udayan

Chief Medical Officer at NextCure, Inc. · on record since Feb 6, 2025

Insider trading activity of Guha Udayan

Transactions on record: 1; since Feb 3, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 3, 2026

Figures computed from official regulatory filings — methodology.

Companies where Guha Udayan has traded

NextCure, Inc.1 tx · Feb 3, 2026

Track record of Guha Udayan

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Guha Udayan

Co-insiders of Guha Udayan

Alexandria Venture Investments, LLCNextCure, Inc.
Bingham James B.NextCure, Inc.
Borgman Anne ElizabethNextCure, Inc.
Canaan Partners X LLCNextCure, Inc.
CANAAN X L.P.NextCure, Inc.
Cobourn Steven P.NextCure, Inc.
Feigal EllenNextCure, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Hainan Simcere Zaiming Pharmaceutical Co., Ltd.NextCure, Inc.

HEALY JAMESNextCure, Inc.

Heller Kevin N.NextCure, Inc.

Houston John GNextCure, Inc.

Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd.NextCure, Inc.

Jones Elaine VNextCure, Inc.

KABAKOFF DAVID SNextCure, Inc.

Khuong Chau QuangNextCure, Inc.

Kundu SouravNextCure, Inc.

Langermann SolNextCure, Inc.

Li JudithNextCure, Inc.

Liu LindaNextCure, Inc.

Mayer TimothyNextCure, Inc.

Mehra AnandNextCure, Inc.

Morrison BriggsNextCure, Inc.

Myint HanNextCure, Inc.

Nicholson Garry ANextCure, Inc.

ORBIMED ADVISORS LLCNextCure, Inc.

OrbiMed Capital GP VI LLCNextCure, Inc.

POWELL MICHAELNextCure, Inc.

Quan Venture Fund II, L.P.NextCure, Inc.

Ren JinshengNextCure, Inc.

Richman MichaelNextCure, Inc.

SHANNON TIMOTHY MNextCure, Inc.

Shaw Kevin G.NextCure, Inc.

Simcere Pharmaceutical Group LtdNextCure, Inc.

Simcere Zaiming, Inc.NextCure, Inc.

Sofinnova Management IX, L.L.C.NextCure, Inc.

Sofinnova Venture Partners IX, L.P.NextCure, Inc.

Tang RenhongNextCure, Inc.

Webster Stephen WNextCure, Inc.

Xu StellaNextCure, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
NextCure, Inc.	Feb 3, 2026	AwardD	14,670	0.00 USD	$0	SEC